Top Markets
Coin of the day
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Pozycja w akcjach #41550
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Cena akcji
$0.0005
Ostatnia synchronizacja: 2026-08-12
Kapitalizacja rynkowa
$16.62K
Zmiana (1 dzień)
-64.29%
Zmiana (1 rok)
400.00%
Kraj
US
Handel WayPoint Biomedical Holdings, Inc. (WYPH)

Kategoria

Historia ceny akcji dla WayPoint Biomedical Holdings, Inc. (WYPH)
Najwyższa cena zamknięcia: $0.00 dnia 2026-08-01

Najniższa cena zamknięcia: $0.00 dnia 2015-04-01
Historia cen akcji firmy WayPoint Biomedical Holdings, Inc. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 236.36%
2024 -50.00%
2023 -99.05%
2022 -78.33%
2021 409.68%
2020 2,254.43%
2019 711.43%
2018 -86.95%
2017 666.00%
2016 233.33%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$201.56 -10.46%
US
$104.88 -39.17%
CA
$29.11 -38.92%
US
$13.84 -8.85%
AU
$61.48 50.91%
US